Genome-wide association studies and genetic analyses have identified a clinically prevalent alteration in the Mycobacterium tuberculosis genome that rewires bacterial propionate metabolism, conditionally reduces antibiotic killing without affecting minimum inhibitory concentrations, and may drive emergence of drug resistance.
References
Brauner, A., Fridman, O., Gefen, O. & Balaban, N. Q. Nat. Rev. Microbiol. 14, 320–330 (2016).
Hicks, N. D. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-018-0218-3 (2018).
Dolan, S. K. et al. Microbiology 164, 251–259 (2018).
Fridman, O., Goldberg, A., Ronin, I., Shoresh, N. & Balaban, N. Q. Nature 513, 418–421 (2014).
Van den Bergh, B. et al. Nat. Microbiol. 1, 16020 (2016).
Levin, B. R. & Rozen, D. E. Nat. Rev. Microbiol. 4, 556–562 (2006).
Levin-Reisman, I. et al. Science 355, 826–830 (2017).
Hu, H. W. et al. Nat. Microbiol. 1, 16147 (2016).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Dick, T., Dartois, V. TB drug susceptibility is more than MIC. Nat Microbiol 3, 971–972 (2018). https://doi.org/10.1038/s41564-018-0226-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-018-0226-3
- Springer Nature Limited